The Competitiveness of Nations
in a Global Knowledge-Based Economy
H.H. Chartrand
April 2002
The
Economics of Biotechnology & Intellectual Property Rights
Ultimately the biotechnology sector rests on the
legal foundation of intellectual property rights (IPRs).
It is ‘fueled’ by new knowledge generated, for example, by biotech
‘star’ innovators (Zucker et al 1998) that then becomes economic property
through the agency of IPRs and thereby provides the legal foundation for the
industrial organization of the sector.
Economics Helps
Economics illuminates the matter by recognizing
that IPRs ‘commodify’ knowledge allowing it to be bought and sold in spite of
its nature as a non-rivalrous and non-exclusionary good.
Such rights are created by the State as a protection of, and incentive
to, creativity which otherwise could be used freely by others.
In economic terms, without legislation, knowledge suffers the
free-rider problem.
In return, the State expects creators to make their work available and
that a market will be created in which such work can be bought and sold.
But while the State wishes to encourage creativity, it does not want to
foster harmful market or ‘monopoly’ power.
Accordingly, the State builds in limitations embracing both time and
space. Rights are granted for a
fixed period of time, and protect only the fixation of creativity in material
form. Eventually, therefore,
intellectual property enters the public
domain where it may be used by everyone without charge or limitation.
Economics Fails
Currently, economics does not provide an
adequate or holistic explanation of the complex nature, formulation, optimal
application and exchange of IPRs. Partially
this reflects that, as with microeconomic data (Part
I, para 2.02), economics relies on other disciplines, specifically
law and political studies, to create, monitor and mutate these rights and
thereby determine what is actually bought and sold in economic exchange.
In effect, mainstream economic thought reifies the legal complexity
and economic richness of IPRs into ‘goods and services’.
This, in turn, reflects a more general
failure to ‘root’ in economic theory (i.e., married to, or otherwise
associated with, utility and marginal revenue), the evolutionary nature of
property rights. The closest the
mainstream has come to the legal foundations of capitalism is “New
Institutional” or the ‘transaction cost’ school of thought (Coase 1937; 1974,
1978, 1992, 1998).
Only two schools of thought, both long ‘dead’,
raised the elemental question of what is actually bought and sold in an
economic transaction. A third
touched a related chord. A fourth
rang the bell of innovation or ‘creative destruction’ but in the legal
stratosphere of Capitalism, Socialism &
Democracy (Schumpeter 1950), i.e., corporate vs. public property rights -
democratically defined.
The first was the Physiocrats (Part IV).
To quote Samuels:
Thus did the Physiocrats implicitly recognize
that the basic economic institutions (the organization of economy) are legal
in character; that law is an instrument for the attainment of economic
objectives and that economy is an object of legal control. (Samuels 1962, 162)
The second was the ‘Old Institutionalism’ of
John R. Commons (Commons 1924). In
addition to the legal implications of economic
futurity (Commons 1950), Commons
characterized the evolutionary nature of property rights as the trend towards
increasing command over the future actions of economic agents.
Both the Physiocrats and Commons became marooned in the backwaters of
economic thought.
The third was the Austrian school in general but
specifically the ‘economy of knowledge’ or ‘price system’
The
Problem
Taking the microeconomic term ‘minimax’ to stand
for the economic criterion of minimizing cost and maximizing revenue:
To minimax one must know what is being
minimaxed! Thus, as I
understand it, in the past, and on “the Continent” (as the British would
say), one first became a lawyer then an economist;
Each of the major forms of intellectual
property (copyrights, patents, registered designs and trademarks) are, in
law, ‘bundles of rights’ (Samuels 1962)
most of the economic literature has focused on
knowledge spillovers (Audretsh and Stephan 1999) and appropriation due to
the inadequacy of IPRs; little has dealt with manipulation of these
‘bundles” to efficiently direct the innovation process, e.g., in the way the
Physiocrats wanted to direct the
laissez faire, laissez passer
marketplace
The Physiocratic theory of economic policy is
fundamentally related to a theory of property: state relations in which
private property is the dominant institutional form but wherein the public
interest is manifest in the continuing modification or reconstitution of the
bundle of rights that comprise private property at any given time. (Samuels
1962, 161)
A BUNDLE
OF RIGHTS APPROACH TO IPRs
Drawing on Adler – a lawyer (1984), a bundle of
IPRs could include:
Alternatively, if one were to imagine each major
class of IPRs (copyrights, patents, registered designs and trademarks) as
different and distinct types of ‘gears’ with many blades or teeth of varying
thicknesses and lengths then each State (subject to international convention)
may sharpen, lengthen, thicken or otherwise vary a bundle of generic rights to
fashion the national motor of innovation. Such rights include, among others, (Exhibit
1):
Adaptation
Assignment
Breadth
Duration
Eligibility
Licensing
National Treatment
Scope
Subject Matter
Transfer
Translation

An elementary demonstration of the explanatory
and policy potential of a ‘bundle of rights’ approach can be drawn from
Eswaran and Gallini (1996). In
essence, they propose that after a pioneering innovation there follows two
alternative patent development paths:
process innovation – the vertical improvement
of the now existing product; and/or,
product innovation – the horizontal addition
to the market of a new product exhibiting product differentiation reflecting
different tastes or needs of ‘consumers’ rather than a new or ‘superior’
product per se.
Development of an ‘optimum’ public patent policy
involves varying:
product breadth: proximity of an
imitator product to infringement;
and/or,
process breadth: proximity of an imitator
process to infringement; that is,
the legal definition (legislature and court)
of what constitutes defense against infringement, e.g., better, cheaper or
novel, and under what circumstances and in what industries.
Optimum public patent policy would foster,
according to Eswaran and Gallini:
more efficient entry if it favoured broad
process but narrow product patents when a pioneer’s R&D costs are low;
and/or,
greater product differentiation if it favoured
broad product but narrow process patents when a pioneer’s R&D costs are
high.
Conclusion
Economics aids understanding of IPRs by
‘commodifying’ them. In the
process, however, mainstream economics has lost sight of what
References
Adler, R. G.,
Biotechnology as an
Intellectual Property, Science, 224 4647, 1984/04/27,
357-363.
Audretsch, D. B and Stephan P. E., “Knowledge
spillovers in biotechnology: sources and incentives”, Journal of
Evolutionary Economics, 1999, 9 97-107.
Coase, R. H. "Evolution, Selection and the Economic Principle - Discussion." American Economic Review, May 1978, 68 (2), 244-245.
Coase, R. H. "The Institutional Structure of Production." American Economic Review, September 1992, 82 ( 4), 713-719.
Coase, R. H. "The Market for Goods and the Market for Ideas." American Economic Review, May 1974, 64 ( 2), 384-391.
Coase, R. H. "The Nature of the Firm." Economica, November 1937, 4 (16), 396-405.
Coase,
R. H. "The New Institutional Economics." American Economic Review, May
1998, 88 ( 2), 72-74.
Commons, John R.,
The Legal
Foundations of Capitalism
- Chapter VII: The Price Bargain, © 1924, Macmillan, NYC,
1939.
Commons,
"Institutional
Economics",
American Economic Review,
vol. 21 (1931), pp.648-657.
Commons, J.R.,
The Economics of Collective Action:
Chapter viii.
FUTURITY
Eswaran, M. and Gallini N., Patent Policy and
the Direction of Technological Change,
RAND Journal of Economics, 27 4, 1996/Winter, 722-746.
[product/process optimality]
Fountain, H., DNA Ditties: Song of Myself,
New York Times,
Hayek, F.A., "The
Use of Knowledge in Society", American Economic Review, Vol.
35, No. 4, Sept, 1945, pp. 519-530.
Hayek, F.A., "The
Pretence of Knowledge", American Economic Review, Vol. 79,
No. 6, Dec. 1989, pp. 3-7.
Samuels,W.J., "The
Physiocratic Theory of Property and State", Quarterly Journal of
Economics, 75(1), Feb. 1961, pp. 96-111.
Samuels, W.J., "The
Physiocratic Theory of Economic Policy", Quarterly Journal of
Economics, 76(1), Feb. 1962, pp. 145-162.
Schumpeter, J.A., Capitalism, Socialism and Democracy, 3rd Ed., -
Chapter VII - The Process of Creative Destruction, 1950, Harper
Zucker, L. G. et al, “Intellectual Capital and
the Birth of U.S. Biotechnology Enterprises”, American Economic Review,
March 1998, 88 (1), 290-306.
The Question
Pick one problem/issue/concern related to
biotechnology (e.g. growth, location, ownership, distribution of benefits,
industrial structure …) and:
1.
define the problem clearly and succinctly;
2.
using the economic literature from the class (and elsewhere) address:
a.
how economics helps to illuminate the problem (it may do so in more
than one way); and
b.
economics’ limitations in addressing the problem
c.
NOTE: you are expected to
refer to at least 5 of your specific readings and 5 other readings on the
syllabus in your answer.
Your mark will be assigned based on the
structure of your talk, the completeness of the answer and the appropriateness
of the references you cite.